Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Clinical Trial Demonstrates the Commercial Value of the Promino Amino Acid Blend (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Biden administration is finalizing contracts with six compan
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(207)
•••
Comment by InvrsContrarianon Feb 09, 2021 4:14am
263 Views
Post# 32510120

RE:Biden administration is finalizing contracts with six compan

RE:Biden administration is finalizing contracts with six companFor those of yous who were worried that stagezero planned for covid testing to stay strong during 2021 and thought that this revenue would go away and make their MD&A plans messed up , well you were wrong, looks like steady income for the next few quarters. Time to test out our capacity for testing, an opportunity to trial test our machinery for Aristotle testing forthcoming. Imagine running full out with 3-5000$ Aristotle tests everyday all day after the covid testing has faded away. Ah such a far away wish.
WHATTHE1 wrote:

"NEW YORK – Members of the White House COVID-19 Response Team announced on Friday that the Biden administration is finalizing contracts with six companies to quickly increase domestic testing capability for at-home SARS-CoV-2 tests."

https://www.modernhealthcare.com/safety-quality/biden-administration-finalizing-six-contracts-increase-home-covid-testing
 



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities